This suggests that the C-terminal domain, which forms endotrophin, explains the effect of COL6A3 on CAD, and the aptamer binding to the C-terminal of COL6A3 may capture the plasma levels of endotrophin or endotrophin-containing fragments. The gene discussed is COL6A3; the disease is coronary artery disorder.